Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Multi-allergen oral immunotherapy may reduce treatment time overall but also led to ...
More than 60% of participant dietary consumption plans showed no significant difference between omalizumab and multi-food oral immunotherapy success rates after 12 months MILWAUKEE, Feb. 22, 2026 ...
HealthDay News — Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results